Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 301 - 305 out of 328
Wailzer, B, Klocker, J, Buchbauer, G, Ecker, G & Wolschann, KP 2001, 'Prediction of the aroma quality and the threshold values of some pyrazines using artificial neural networks', Journal of Medicinal Chemistry, vol. 44, no. 17, pp. 2805-2813. https://doi.org/10.1021/jm001129m
Annibali, D, Ecker, G, Fleischhacker, W, Helml, T, Holzer, W & Noe, C 2000, 'A method for the synthesis of 2,3-disubstituted 2,3-dihydrobenzofurans', Monatshefte für Chemie, vol. 131, no. 4, pp. 375-382. https://doi.org/10.1007/s007060050318
Kaiser, D, Tmej, C, Chiba, P, Schaper, K-J & Ecker, G 2000, 'Artificial neural networks in drug design II: Influence of learning rate and momentum factor on the predictive ability', Scientia Pharmaceutica, vol. 68, no. 1, pp. 57-64.
Ecker, G, Langer, T & Wolschann, KP 2000, 'Scientia pharmaceutica: Editorial', Scientia Pharmaceutica, vol. 68, no. 1. <http://www.scopus.com/scopus/inward/record.url?eid=2-s2.0-0034732303&partner@&rel=R5.0.4>
Buchstaller, H-P, Siebert, CD, Lyssy, RH, Ecker, G, Krug, M, Berger, M, Gottschlich, R & Noe, C 2000, 'Thieno (2,3-b) pyridinones as Antagonists on the Glycine Site of the N-methyl-D-asparatate Receptor-Binding Studies, Molecular Modeling and Structure-Activity-Relationships', Scientia Pharmaceutica, no. 68, pp. 3-14.
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding